Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:12673804rdf:typepubmed:Citationlld:pubmed
pubmed-article:12673804lifeskim:mentionsumls-concept:C0023452lld:lifeskim
pubmed-article:12673804lifeskim:mentionsumls-concept:C0919524lld:lifeskim
pubmed-article:12673804lifeskim:mentionsumls-concept:C0596611lld:lifeskim
pubmed-article:12673804pubmed:issue5lld:pubmed
pubmed-article:12673804pubmed:dateCreated2003-4-3lld:pubmed
pubmed-article:12673804pubmed:abstractTextHereditary ATM gene mutations cause ataxia-telangiectasia, a pleiotropic disorder associated with a high incidence of lymphoid malignancies. Acquired ATM alterations have been described in sporadic lymphoproliferative disorder suggesting that the ATM gene contributes to lymphomagenesis. To assess the prevalence of genomic ATM alterations in childhood acute lymphoblastic leukemias (ALL), we explored a series of 57 sporadic ALL cases (26 B-precursor ALL and 31 T-ALL) using DHPLC (Denaturing High-Performance Liquid Chromatography). We identified 28 distinct genomic ATM alterations in 14 patients (25%). Ten of them were scored as probably biologically significant and appear to be associated with a high risk of relapse (P<0.01). Six alterations of potential biological significance were observed in 5 cases of B-precursor ALL (19%), while 5 were found in 3 cases of T-ALL (10%). In two cases of B-precursor ALL, the ATM alterations were found in the germline, indicating an ATM carrier status. We report here the high prevalence of genomic ATM alterations in childhood ALL. Our observations lend further support to the postulated contribution of ATM in lymphomagenesis.lld:pubmed
pubmed-article:12673804pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12673804pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12673804pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12673804pubmed:languageenglld:pubmed
pubmed-article:12673804pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12673804pubmed:citationSubsetIMlld:pubmed
pubmed-article:12673804pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12673804pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12673804pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12673804pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12673804pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12673804pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12673804pubmed:statusMEDLINElld:pubmed
pubmed-article:12673804pubmed:monthMaylld:pubmed
pubmed-article:12673804pubmed:issn1098-1004lld:pubmed
pubmed-article:12673804pubmed:authorpubmed-author:WackerPierrePlld:pubmed
pubmed-article:12673804pubmed:authorpubmed-author:BettsDavidDlld:pubmed
pubmed-article:12673804pubmed:authorpubmed-author:SappinoAndré-...lld:pubmed
pubmed-article:12673804pubmed:authorpubmed-author:Gumy...lld:pubmed
pubmed-article:12673804pubmed:authorpubmed-author:MailletPhilip...lld:pubmed
pubmed-article:12673804pubmed:copyrightInfoCopyright 2003 Wiley-Liss, Inc.lld:pubmed
pubmed-article:12673804pubmed:issnTypeElectroniclld:pubmed
pubmed-article:12673804pubmed:volume21lld:pubmed
pubmed-article:12673804pubmed:ownerNLMlld:pubmed
pubmed-article:12673804pubmed:authorsCompleteYlld:pubmed
pubmed-article:12673804pubmed:pagination554lld:pubmed
pubmed-article:12673804pubmed:dateRevised2011-11-2lld:pubmed
pubmed-article:12673804pubmed:meshHeadingpubmed-meshheading:12673804...lld:pubmed
pubmed-article:12673804pubmed:meshHeadingpubmed-meshheading:12673804...lld:pubmed
pubmed-article:12673804pubmed:meshHeadingpubmed-meshheading:12673804...lld:pubmed
pubmed-article:12673804pubmed:meshHeadingpubmed-meshheading:12673804...lld:pubmed
pubmed-article:12673804pubmed:meshHeadingpubmed-meshheading:12673804...lld:pubmed
pubmed-article:12673804pubmed:meshHeadingpubmed-meshheading:12673804...lld:pubmed
pubmed-article:12673804pubmed:meshHeadingpubmed-meshheading:12673804...lld:pubmed
pubmed-article:12673804pubmed:meshHeadingpubmed-meshheading:12673804...lld:pubmed
pubmed-article:12673804pubmed:meshHeadingpubmed-meshheading:12673804...lld:pubmed
pubmed-article:12673804pubmed:meshHeadingpubmed-meshheading:12673804...lld:pubmed
pubmed-article:12673804pubmed:meshHeadingpubmed-meshheading:12673804...lld:pubmed
pubmed-article:12673804pubmed:meshHeadingpubmed-meshheading:12673804...lld:pubmed
pubmed-article:12673804pubmed:meshHeadingpubmed-meshheading:12673804...lld:pubmed
pubmed-article:12673804pubmed:meshHeadingpubmed-meshheading:12673804...lld:pubmed
pubmed-article:12673804pubmed:meshHeadingpubmed-meshheading:12673804...lld:pubmed
pubmed-article:12673804pubmed:meshHeadingpubmed-meshheading:12673804...lld:pubmed
pubmed-article:12673804pubmed:meshHeadingpubmed-meshheading:12673804...lld:pubmed
pubmed-article:12673804pubmed:year2003lld:pubmed
pubmed-article:12673804pubmed:articleTitleATM gene alterations in childhood acute lymphoblastic leukemias.lld:pubmed
pubmed-article:12673804pubmed:affiliationDepartment of Pediatrics, Unit of Hematology/Oncology, University Hospital of Geneva, Switzerland. Fabienne.GumyPause@medecine.unige.chlld:pubmed
pubmed-article:12673804pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:12673804pubmed:publicationTypeResearch Support, U.S. Gov't, P.H.S.lld:pubmed
pubmed-article:12673804pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed